Literature DB >> 31612352

A multi-state model based reanalysis of the Framingham Heart Study: Is dementia incidence really declining?

Nadine Binder1, James Balmford2,3, Martin Schumacher3.   

Abstract

Recent research by Satizabal and colleagues using data from the Framingham Heart Study demonstrated a linear decline in dementia incidence since the 1970s. The aim of this study is to re-examine these findings, given concerns that bias resulted from failure to account for the probability of acquiring dementia between the last dementia-free observation and death. This analysis included 5118 persons 60+ years of age, and determined the 5-year dementia incidence during four non-overlapping epochs. In addition to a replication using Cox proportional hazards, we applied separate Cox models (given unequal hazards across epochs) and a Spline-based penalized likelihood approach based on the illness-death multi-state model. In addition, we present a simulation study demonstrating the bias associated with the use of standard survival models. The simulation showed that estimates of disease incidence derived from the multi-state model-based approach were consistent with the true disease incidence, whereas Cox regression 'censoring' observations at death or at last observation consistently underestimated it. Using the Framingham data, the 5-year age- and sex-adjusted cumulative hazard rates for dementia as derived from the multi-state model-based approach were 3.84, 2.66, 3.29 and 3.13 per 100 persons in epochs 1, 2, 3 and 4 respectively. The findings do not support the conclusion that dementia incidence has declined in the Framingham Heart Study over the given time period. Previous findings of a decline may have been an artefact resulting from improper treatment of those cases in which death precluded the observation of dementia onset.

Entities:  

Keywords:  Dementia; Epidemiological biases; Framingham Heart Study; Incidence; Multi-state model

Mesh:

Year:  2019        PMID: 31612352     DOI: 10.1007/s10654-019-00567-6

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  27 in total

1.  Multiple imputation for estimating the risk of developing dementia and its impact on survival.

Authors:  Binbing Yu; Jane S Saczynski; Lenore Launer
Journal:  Biom J       Date:  2010-10       Impact factor: 2.207

2.  The combined association of alcohol consumption with dementia risk is likely biased due to lacking account of death cases.

Authors:  Nadine Binder; Lisa Manderscheid; Martin Schumacher
Journal:  Eur J Epidemiol       Date:  2017-05-15       Impact factor: 8.082

Review 3.  The global prevalence of dementia: a systematic review and metaanalysis.

Authors:  Martin Prince; Renata Bryce; Emiliano Albanese; Anders Wimo; Wagner Ribeiro; Cleusa P Ferri
Journal:  Alzheimers Dement       Date:  2013-01       Impact factor: 21.566

4.  Missing information caused by death leads to bias in relative risk estimates.

Authors:  Nadine Binder; Martin Schumacher
Journal:  J Clin Epidemiol       Date:  2014-06-30       Impact factor: 6.437

5.  Trends in dementia incidence: Evolution over a 10-year period in France.

Authors:  Leslie Grasset; Carol Brayne; Pierre Joly; Hélène Jacqmin-Gadda; Karine Peres; Alexandra Foubert-Samier; Jean-François Dartigues; Catherine Helmer
Journal:  Alzheimers Dement       Date:  2015-12-13       Impact factor: 21.566

6.  A semi-competing risks model for data with interval-censoring and informative observation: an application to the MRC cognitive function and ageing study.

Authors:  Jessica K Barrett; Fotios Siannis; Vern T Farewell
Journal:  Stat Med       Date:  2010-11-05       Impact factor: 2.373

Review 7.  Is dementia incidence declining in high-income countries? A systematic review and meta-analysis.

Authors:  Susanne Roehr; Alexander Pabst; Tobias Luck; Steffi G Riedel-Heller
Journal:  Clin Epidemiol       Date:  2018-09-18       Impact factor: 4.790

8.  Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet Neurol       Date:  2018-11-26       Impact factor: 44.182

9.  Identifying dementia outcomes in UK Biobank: a validation study of primary care, hospital admissions and mortality data.

Authors:  Tim Wilkinson; Christian Schnier; Kathryn Bush; Kristiina Rannikmäe; David E Henshall; Chris Lerpiniere; Naomi E Allen; Robin Flaig; Tom C Russ; Deborah Bathgate; Suvankar Pal; John T O'Brien; Cathie L M Sudlow
Journal:  Eur J Epidemiol       Date:  2019-02-26       Impact factor: 8.082

10.  Compression or expansion of dementia in Germany? An observational study of short-term trends in incidence and death rates of dementia between 2006/07 and 2009/10 based on German health insurance data.

Authors:  Gabriele Doblhammer; Anne Fink; Stephanie Zylla; Frans Willekens
Journal:  Alzheimers Res Ther       Date:  2015-11-05       Impact factor: 6.982

View more
  3 in total

1.  The Role of Dementia Diagnostic Delay in the Inverse Cancer-Dementia Association.

Authors:  Eleanor Hayes-Larson; Crystal Shaw; Sarah F Ackley; Scott C Zimmerman; M Maria Glymour; Rebecca E Graff; John S Witte; Lindsay C Kobayashi; Elizabeth Rose Mayeda
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-06-01       Impact factor: 6.591

2.  Objectives, design and main findings until 2020 from the Rotterdam Study.

Authors:  M Arfan Ikram; Guy Brusselle; Mohsen Ghanbari; André Goedegebure; M Kamran Ikram; Maryam Kavousi; Brenda C T Kieboom; Caroline C W Klaver; Robert J de Knegt; Annemarie I Luik; Tamar E C Nijsten; Robin P Peeters; Frank J A van Rooij; Bruno H Stricker; André G Uitterlinden; Meike W Vernooij; Trudy Voortman
Journal:  Eur J Epidemiol       Date:  2020-05-04       Impact factor: 8.082

3.  Healing, surviving, or dying? - projecting the German future disease burden using a Markov illness-death model.

Authors:  Valeska Milan; Stefan Fetzer; Christian Hagist
Journal:  BMC Public Health       Date:  2021-01-11       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.